Continuing Education Online Courses
The continuing medical education online activities listed below include topics in a wide variety of therapeutic areas. We feature a variety of formats and learning opportunities to suit your needs. All content is developed and approved by experts and includes up-to-date data and research. Whether you are participating from your office, at home, or via mobile device, we offer continuing education online courses for you. Browse through the subjects below or click Therapeutic Areas above to find educational opportunities in your content area.
This interactive and fast-paced activity will test your knowledge and practice with multiple choice questions and patient case vignettes. You will learn what the expert has to say about treatment approaches in moderate-to-severe and difficult-to-treat pediatric asthma, as well as have the opportunity to compare yourself to your peers.
In preparation for an archived webinar, you will complete this self-study module which includes case reviews and the opportunities to pose questions and interact with faculty members.
This interactive and fast-paced activity will allow you to test your knowledge and practice via a series of multiple choice questions. The program includes case vignettes, an opportunity to test your knowledge against your peers, and expert guidance about treatment approaches in HER2-postive breast cancer.
Designed for researchers in hematology/oncology and for hematologists and oncologists who diagnose and treat patients with hematologic malignancies, this program provides cutting-edge research about newly approved and emerging treatments for leukemia, lymphoma, and myeloma.
Based on the proceedings from a live continuing medical education series, this interactive multichallenge activity will discuss issues and updates in hereditary angioedema (HAE). Faculty experts provide commentary on the newest developments in HAE while patient case challenges test your knowledge and skill in diagnosing and treating HAE.
This activity calls upon experts to provide evidence-based support and clinical rationale for using PCSK9 inhibitors when treating patients with hypercholesterolemia. Participants will complete interactive case challenges to learn about patient eligibility and required documentation for payers via the use of clinical trial and tolerability data.
This activity provides evidence-based support and clinical rationale for incorporating PCSK9 inhibitors into the treatment of patients with hypercholesterolemia. Through interactive case challenges, participants will understand patient eligibility and required documentation for payers, using clinical trial and tolerability data.
Inflammatory Bowel Diseases
This Clinical Convergence® activity is unique in its integration of healthcare provider and patient perspectives. It includes clinical content that zeroes in on certain aspects of inflammatory bowel disease (IBD) care, such as personalized treatment decisions, patient/drug monitoring, and shared decision making.
This case-based activity for physicians, gastroenterologists, nurse practitioners, and physician assistants presents a patient whose symptoms are consistent with inflammatory bowel disease (IBD). Participants are able to virtually diagnose, treat, and manage the patient while learning from expert faculty.
This activity helps physicians, gastroenterologists, nurse practitioners, and physician assistants choose acute and long-term medical therapy for inflammatory bowel disease (IBD) and decide when surgery is indicated.
This activity explores the Crohn's & Colitis Foundation's IBD Nutrition Care Pathway with 2 video segments in which a physician, a dietitian, and a patient with IBD discuss malnutition.
The IBD Nutrition Care Pathway from the Crohn's and Colitis Foundation is beneficial in the screening, evaluation, intervention, and follow-up of IBD patients and patients with malnutrition. This activity will provide education on the application of key elements of this pathway, as well as 2 video segments of panel discussions between a physician, a dietitian, and a patient with IBD.
This activity is intended for gastroenterologists, gastroenterology nurse practitioners, and PAs who actively manage patients with inflammatory bowel disease (IBD), as well as managed care directors and hospital pharmacists interested in IBD treatment options.
Metastatic Gastric Cancer
In this interactive activity you will receive updates on recent developments in gastric/GEJ cancer treatment, as well as the opportunity to compare your question responses to those of your peers.
Non-Small Cell Lung Cancer
A QI project on quality measures in the treatment of advanced NSCLC has been initiated by Cancer Care Partners, a virtual oncology clinic system. In this program, the QI team's progress will be reviewed, and participants will have the opportunity to interact with them as the QI initiative progresses.
Solid Organ Transplant
This educational activity is based on the proceedings of a symposium at the 2018 American Transplant Congress. Drs. Deepali Kumar and Alexandre Loupy present new data and challenging clinical cases in cytomegalovirus (CMV) and antibody-mediated rejection (AMR) in transplantation. You will have an opportunity to assess your skills in CMV and AMR and compare your responses to your peers when you answer interactive questions throughout the activity.
This article reviews the pathophysiology of antibody‐mediated rejection (AMR) and the required features for a definitive diagnosis of AMR according to the latest Banff criteria. Clinical data on current and investigational treatments are summarized, strategies to improve outcomes are presented, and a discussion of relevant predictive and surrogate endpoints provides a framework for future studies.